ABSTRACT
Artificial Intelligence (AI) in drug discovery is a rapidly evolving field that combines computational methods with biological knowledge and applications. Traditionally, the process of developing a new drug has been time-consuming and expensive, spanning several years and costing billions of dollars. The emergence of AI technologies offers the potential to significantly reduce both the timeline and cost involved in this critical endeavour. However, it is crucial to acknowledge that AI applications in pharmacy and drug discovery require a high degree of interpretability and transparency. The integration of domain knowledge into AI models becomes paramount to ensure the reliability and trustworthiness of the generated results. In light of these considerations, we propose a workshop on "Knowledge-enhanced Artificial Intelligence in Drug Discovery (KAIDD)." This workshop aims to explore the profound impact of incorporating various knowledge databases into the development of explainable AI models for drug discovery. Participants will have the opportunity to delve into cutting-edge research, methodologies, and practical applications that leverage the fusion of AI techniques with domain-specific knowledge. Authors of accepted papers will have the opportunity to submit extended versions of their work for a full-paper review process and potential publication in Philosophical Transactions of the Royal Society B.
Index Terms
- Knowledge-enhanced Artificial Intelligence in Drug Discovery (KAIDD)
Recommendations
Artificial Intelligence for Drug Discovery
KDD '21: Proceedings of the 27th ACM SIGKDD Conference on Knowledge Discovery & Data MiningDrug discovery is a long and costly process, taking on average 10 years and 2.5 billion dollars to develop a new drug. Artificial intelligence has the potential to significantly accelerate the process of drug discovery by analyzing a large amount of ...
Can artificial intelligency revolutionize drug discovery?
AbstractArtificial intelligency can bring speed and reliability to drug discovery process. It represents an additional intelligence, which in any case can replace the strategic and logic creative insight of the medicinal chemist who remains the architect ...
A comprehensive review on recent approaches for cancer drug discovery associated with artificial intelligence
AbstractThrough the revolutionization of artificial intelligence (AI) technologies in clinical research, significant improvement is observed in diagnosis of cancer. Utilization of these AI technologies, such as machine and deep learning, is imperative ...
Highlights- 136 recent papers are comprehensively reviewed for anticancer drug discovery.
- Anticancer drug discovery models based on machine and deep learning are reviewed.
- This paper highlights challenges and future works on anticancer drug ...
Comments